Marinus Pharmaceuticals (NASDAQ:MRNS – Get Free Report) was downgraded by equities research analysts at Oppenheimer from an “outperform” rating to a “market perform” rating in a research note issued to investors on Friday, MarketBeat reports. They presently have a $9.00 price objective on the biopharmaceutical company’s stock, down from their previous price objective of $14.00. […]
Marinus Pharmaceuticals (NASDAQ:MRNS) Releases Earnings Results, Beats Estimates By $0 15 EPS kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
Marinus Pharmaceuticals (NASDAQ:MRNS – Free Report) had its price objective decreased by Robert W. Baird from $24.00 to $20.00 in a report issued on Friday, MarketBeat reports. Robert W. Baird currently has an outperform rating on the biopharmaceutical company’s stock. MRNS has been the topic of a number of other reports. Truist Financial cut their […]
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS – Get Free Report) CFO Steven Pfanstiel sold 2,790 shares of the firm’s stock in a transaction that occurred on Monday, August 7th. The stock was sold at an average price of $9.54, for a total transaction of $26,616.60. Following the completion of the transaction, the chief financial officer now directly […]
Marinus Pharmaceuticals (NASDAQ:MRNS) PT Lowered to $13 00 at LADENBURG THALM/SH SH dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.